France Views

Pages

ERYTECH's Graspa Gains FDA ODD For AML

ERYTECH Pharma's lead product Graspa (erythrocyte-encapsulated L-asparaginase; ERY-ASP) has been granted orphan drug designation (ODD) by the FDA for the treatment of acute myeloid leukaemia (AML).

Read article ›
Pent-Up Demand Buoys Car Sales Growth

Passenger car sales in France increased 2.9% year-on-year (y-o-y) in the first three months of 2014, to 446,648 units. BMI forecasts 2.0% growth in passenger car sales in 2014, as we expect pent-up...

Read article ›

Pages